Report overview
Peptide therapy refers to restoring the amount of peptides to stimulate the cellular regeneration system in the body, and can be an excellent complement to small molecule and biotherapeutics as a treatment option under certain conditions. The most common uses of peptide therapy are to help build muscle and reduce fat, increase energy, improve sexual function, and reduce gastrointestinal and musculoskeletal inflammation. The most common prescription peptide combinations naturally boost growth hormone for better recovery. Peptides were initially used only for diagnostics and hormone therapy; however, as technology has advanced, they are now also widely used to treat cancer and chronic metabolic diseases. Peptides are also used in cosmeceutical operations to slow down the skin's aging process.
This report aims to provide a comprehensive presentation of the global market for Peptide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapy. This report contains market size and forecasts of Peptide Therapy in global, including the following market information:
Global Peptide Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Peptide Therapy Market Sales, 2018-2023, 2024-2032, (K Units)
Global top five Peptide Therapy companies in 2022 (%)
The global Peptide Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Parenteral Route of Administration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Peptide Therapy include Eli Lilly, AstraZeneca, Merck, Ipsen, Novo Nordisk, Teva Pharmaceutical Industries, Abbott Laboratories, Sanofi and J & J, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Peptide Therapy manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Peptide Therapy Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Type, 2022 (%)
Parenteral Route of Administration
Mucosal Route of Administration
Oral Route of Administration
Transdermal Route of Administration
Global Peptide Therapy Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, by Application, 2022 (%)
Cancer
Cardiovascular Diseases
Gastrointestinal Disorders
Metabolic Disorders
Others
Global Peptide Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Units)
Global Peptide Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Peptide Therapy revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Peptide Therapy revenues share in global market, 2022 (%)
Key companies Peptide Therapy sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Peptide Therapy sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly
AstraZeneca
Merck
Ipsen
Novo Nordisk
Teva Pharmaceutical Industries
Abbott Laboratories
Sanofi
J & J
Novartis
Takeda
Ferring
AbbVie
Heinis
Hemmo
Emcure Pharmaceutical
Cipla
Gland Pharma
Troikaa Pharmaceuticals
Biological E
Outline of Major Chapters:
Chapter 1: Introduces the definition of Peptide Therapy, market overview.
Chapter 2: Global Peptide Therapy market size in revenue and volume.
Chapter 3: Detailed analysis of Peptide Therapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Peptide Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Peptide Therapy capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
